Colombia’s Ministry of Health and Social Protection
Colombia’s Ministry of Health and Social Protection
Resolution 002445 of October 22, 2026 opens a direct credit facility through the Administradora de los Recursos del Sistema General de Seguridad Social en Salud (ADRES), with disbursements going straight …
A study led by Rare Diseases International finds rare disease patients in Colombia wait an average of 25 months for a diagnosis, and up to 19 years in some cases.
Colombia’s Consejo de Estado has upheld an order requiring the government to lay the foundations of a new national pharmaceutical policy, with potential consequences for drug pricing, supply, and local …
Colombia’s highest administrative court suspended Decree 0182 on May 4, 2026, freezing a territorial restructuring of health insurers that would have forcibly reassigned an estimated 6.6 million affiliates.
Colombia’s Ministry of Health declared public interest grounds to pursue mandatory licensing of Gilead’s sofosbuvir-based hepatitis C patents, transferring the process to the competition authority for a final determination.
You must be logged in to post a comment.